PIM
GSK icon

Perpetual Investment Management’s GSK GSK Stock Holding History

Perpetual Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-279,424
Closed -$15.2M – 224
2022
Q1 		$15.2M Sell
279,424
-74,890
-21% -$4.07M 1.91% 10
2021
Q4 		$19.5M Buy
354,314
+14,800
+4% +$770K 2.24% 5
2021
Q3 		$16.2M Buy
339,514
+29,472
+10% +$1.48M 2.05% 6
2021
Q2 		$15.5M Buy
310,042
+31,040
+11% +$1.49M 2.2% 5
2021
Q1 		$12.7M Buy
279,002
+67,304
+32% +$3.05M 2.11% 8
2020
Q4 		$9.8M Buy
+211,698
New +$9.72M 1.45% 18

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Perpetual Investment Management's GSK Position: Q2 2022 in Review

Perpetual Investment Management sold out of GSK (GSK) in Q2 2022, closing a stake of 279,424 shares — an estimated $15.2M sold.

Perpetual Investment Management first reported a position in GSK in Q4 2020 and held it in 6 quarters. The position peaked at $19.5M in Q4 2021. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Perpetual Investment Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Perpetual Investment Management sold 279,424 GSK shares in Q2 2022, an estimated $15.2M.
  • Perpetual Investment Management first reported a position in GSK in Q4 2020 and held it in 6 quarters.
  • Perpetual Investment Management's GSK position peaked at $19.5M in Q4 2021.
  • 901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Perpetual Investment Management's 13F filing for Q2 2022, filed 10 Aug 2022.